Member Info for Kettle

Unfortunately she wins, and is always the one with the royal flush! Lol

I am in for the long haul but I see this climbing well as it has acted differently. Look at Amp.jump piggy backing Mtb and in big debt. Now look at what Mtb has after approval the facts will send this up even without other news. I shall apologise if this is wrong on Friday. I want to top up 20 k but cannot get it past the boss. She says I may have four of a kind but a royal flush might be out there, blood poker players!

He can afford his operation now, so he wont just talk like one he will actually have one.

Your previous posts ask why people do not invest straight into mtb rather than amp, make your mind up!

Subtle!

Don’t worry just put Petch007 above it.

Also on tv,John ashwort MP is on the case and just got blanked by company on air. I have contacted show and MP to tell of alternative. It seems all about cost.

So your talking cashing in rather than holding any longer than approval spike?

Higher, Higher

After approval and share price spike, I believe a good offer will be made on spike. As if buyer waits until normal drop all the other treatments will be talked about , cystic f , asthma etc and that will enhance value of stock even more and it will be a blockbuster that has to be bought quickly. I believe Lumsden will play this card and was always going to. It has been done before and history does repeat.

Just joshing, appreciate all posts. Now back to Amp how can they climb so high on the back of mtb and have sooo much debt all they have of value is their shares but the same shares are not working for us. I like the blockbuster opinion though, this is fun now! I think?

Says he who started banging the drum for HUR

Or they have both and stuff us! Would Mr Lumsden do that ?

I thought that was always the case, that’s why I liked the talk of mtb being valued at 1 billion. Of course the fact other avenues of use has not been explored a great deal as well. The buyer gets a super product so either low ball or the other possible uses is a great deal for who.? Hope we get a fair deal as it is win win for buyer.

Buoy you took that well !

Leave him and the ladyboys alone,bring back Catscan!

Thanks Tobias, the only thing that stands out to me is on fast track it needs to be an un-met medical need which I hope is the case as other drugs are meeting the problem just not as well. Anyone give some guidance here or am I being too specific.

It cannot be priced in because until approval,there is nothing there in fact. We cannot let doctors treat people until they are qualified even though they have done all their training. Or drive a car even though they have done all their lessons.
That’s why will will earn money because people are worried buying shares etc. It comes with the territory. The price remains low because 5 times 38 p is less than 5 times 90 p and I believe that is why there has been a fix here but it does stand out so pricing the Company will be interesting on approval.

It seems the fda had been asked what comparisons and how they would like Iclaprim to be monitored for fast track approval. This has been followed, what more could be done ? I think mtb Have played the game well. Our problems will be the peak and troughs after approval

Not a clown or doctor or dentist or stock picker. I would not want a prescription from him either. Does he know looking at his times of entries, his employer will look with interest at his working day no wonder he took a lesser medical role.